MRI-Compatible IV Infusion Pump Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Non-magnetic pumps accounted for 64.12% of the MRI-compatible IV infusion pump market share in 2025, as their ferrous-free architecture eliminates shielding constraints. This segment anchors the current MRI-compatible IV infusion pump market as large centers prioritize unrestricted patient positioning and workflow simplicity. The MRI-compatible IV infusion pump market size tied to non-magnetic units is forecasted to expand in parallel with the installation of new high-field scanners. Magnetic-shielded pumps are gaining traction, advancing at a 10.96% CAGR as compact shielding materials reduce cabinet bulk. B. Braun’s Space MRI Station features eight conventional pumps housed within a mu-metal cloak, appealing to hospitals that have already standardized on B. Braun software. Disposable tubing manufacturers are experimenting with BioDur 108 alloy to reduce the per-procedure cost while meeting sterility standards.

Achieving ultra-quiet operation inside the magnet bore is a core non-magnetic selling point. Clinicians report fewer alarms, reducing scan interruptions. Meanwhile, shielded models utilize familiar pump interfaces, thereby flattening the learning curve for staff who rotate between MRI and standard infusion rooms. Some tertiary centers mix both types: shielded racks for long oncology infusions and non-magnetic portables for anesthesia and contrast bolus work.

Scanners at ≤1.5 T currently account for 42.75% of the MRI-compatible IV infusion pump market share, mirroring installed base realities. However, ultra-high-field systems exhibit the fastest 11.35% CAGR because neuroscience and cardiac research institutes adopt 7 T magnets. The MRI-compatible IV infusion pump market size in this ultra-high-field niche is expected to grow as head-only and extremity scanners transition from research to clinical settings, leading to increased billing codes. Engineering challenges include eliminating eddy-current noise and ensuring Bluetooth telemetry survives intense gradients. Manufacturers collaborate with coil vendors to co-validate pump placement zones, shortening procurement cycles.

Mid-range 3 T machines remain radiology workhorses, sustaining steady replacement demand. Hospitals upgrading from 1.5 T to 3 T often bundle pump refreshes in the same capital cycle, a pattern vendors exploit by packaging service contracts. Payers in Europe are increasingly reimbursing 7T neuro scans for refractory epilepsy diagnostics, a policy catalyst that will nudge more centers toward ultra-high-field compatible pumps.

Bedside units captured 60.95% of the MRI-compatible IV infusion pump market share in 2025, as radiology teams value devices that accompany the patient from pre-scan preparation through post-scan observation. Battery life and a lightweight chassis enable seamless handoffs without repriming lines. The MRI-compatible IV infusion pump market continues to tilt toward portability as ASCs and hybrid ORs schedule same-day discharges. Stationary rack systems remain relevant for lengthy neurovascular procedures that utilize multiple drug channels simultaneously. IRadimed’s newest model weighs under 4 kg, one-third lighter than first-generation designs, and incorporates four-channel capability in a single shell.

Technicians cite faster room turnover when pumps clip directly onto detachable poles rather than large gantry mounts. Meanwhile, rack systems integrate with anesthesia workstations, giving anesthesiologists centralized control. Makers respond by offering modular carts, allowing facilities to start with portables and later add docking bays to expand the channel count without requiring new pump purchases.

Hospitals accounted for 68.74% of the MRI-compatible IV infusion pump market size in 2025. Teaching facilities emphasize research versatility, so they specify pumps operable at multiple field strengths. Multi-campus health networks negotiate enterprise deals, bundling disposables at fixed margins, driving repeat revenue for manufacturers. ASCs post the fastest 12.79% CAGR because payer policies shift elective spine and joint interventions to outpatient settings. Pump vendors target ASCs with leasing programs that minimize the upfront cash requirement.

Specialty clinics—such as pain, neurology, and oncology—seek portable pumps that integrate with electronic medical record systems for automatic charting. Diagnostic imaging centers, once observers, are piloting on-site sedated pediatrics programs and therefore buying a small fleet of non-magnetic pumps. Research institutes procure the earliest prototypes, providing real-world feedback that informs the development of broader commercial versions.

North America retained 44.10% of the MRI-compatible IV infusion pump market size in 2025. The United States drives most placements thanks to early FDA clearances and a concentration of magnet-stocked academic medical centers. Canada’s provincial health systems fund capital grants for intra-operative MRI suites, sustaining replacement cycles. Mexico’s private hospital chains invest in turnkey surgical imaging theaters to attract medical tourists, creating incremental pump demand.Europe remains a mature adopter with stringent, predictable CE-mark pathways. Germany, France, and the United Kingdom favor network-ready pumps that comply with GDPR for device data. Scandinavian countries pilot closed-loop infusion protocols inside 3 T neurosurgical theaters, a model under review by EU health technology assessment bodies. Russia’s neuroscience institutes continue to import ultra-high-field capable pumps despite broader equipment sanctions, sustaining a small but resilient niche.

Asia-Pacific posts the strongest 12.98% CAGR. China’s National Health Commission earmarked funds for county-level MRI expansion, spurring local contract manufacturers to license Western pump IP and reduce import tariffs. India’s government-backed 1.5 T scanner line aspires to halve magnet pricing, indirectly lifting pump affordability. Japan pioneers IoT integration, linking infusion pumps with radiology scheduling systems to auto-populate drug libraries. Southeast Asian markets, led by Thailand and Indonesia, see private hospital groups differentiate premium packages with MRI-guided pain ablation services, fueling pump uptake.

The Middle East invests in flagship transplant centers where high-field MRI supports intra-op vascular mapping. Saudi Arabia’s Vision 2030 hospital projects include hybrid suites pre-wired for non-magnetic pumps. South America advances more slowly; however, Brazil’s top oncology institutes trial AI-assisted 3 T therapy workflows that require pump interoperability, hinting at future scale.